Skip to main content

4 Result(s)

within Alan W Craft Remove this filter Medicine & Public Health Remove this filter Pharmacology/Toxicology Remove this filter

and

  1. No Access

    Article

    Prohibitive toxicity of a dose-intense regime for metastatic neuroblastoma containing ifosfamide, doxorubicin and cisplatin

    Three patients with stage 4 neuroblastoma were treated with a schedule comprising alternating modules of myelosuppressive (ifosfamide, etoposide, doxorubicin) and less myelosuppressive (vincristine, cisplatin)...

    Stephen P. Lowis, Andrew D. J. Pearson… in Cancer Chemotherapy and Pharmacology (1993)

  2. No Access

    Article

    Assessment of chemotherapy-associated nephrotoxicity in children with cancer

    Assessment of the toxicity caused by chemotherapy in children with cancer has become more important as the number of long-term survivors has continued to increase. It is vital to monitor both acute life-threat...

    Roderick Skinner, Andrew D. J. Pearson… in Cancer Chemotherapy and Pharmacology (1991)

  3. No Access

    Article

    Toxicity of high-dose ifosfamide in children

    Ifosfamide has been shown to be an active agent in the treatment of several childhood cancers. However, the optimal dose and method of administration remains to be established. The dose/response relationship o...

    Stella M. Davies, Andrew D. J. Pearson… in Cancer Chemotherapy and Pharmacology (1989)

  4. No Access

    Article

    Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia

    Repeated methotrexate absorption studies were performed under standard conditions in 127 children receiving either oral or intramuscular methotrexate for acute lymphoblastic leukaemia. There was marked variabi...

    Andrew D. J. Pearson, Steven Mills… in Cancer Chemotherapy and Pharmacology (1987)